IBIO-600

· iBio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBIO-600, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults [Phase 1]

See pricing